Skip to content
Volume 33, Issue 4
  • ISSN: 0032-1400


It is now 20 years since the publication of the anti-tumour activity of platinum compounds by Barnett Rosenberg and his colleagues. During this time platinum-based drugs have made a major contribution to cancer therapy with significant benefits for many patients. This article summarises the history of platinum agents in this field and indicates the current and possible future directions of research.


Article metrics loading...

Loading full text...

Full text loading...



  1. Rosenberg B., VanCamp L., Trosko J. E., and Mansour V. H. Nature, 1969, 222, 385 [Google Scholar]
  2. and Roberts J. J. “Platinum Coordination Complexes in Cancer Chemotherapy”, ed. Connors T. A., Springer-Verlag, New York, 1974Biochimie, 1978, 60, (9), 835965 [Google Scholar]
  3. Crooke S. T., and Carter S. K. “Cisplatin—Current Status and New Developments”, ed. Prestayko A. W., Academic Press, New York, 1980 [Google Scholar]
  4. Nicolini M. “Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy”, ed. Martinus Nijhoff, Boston, 1988 [Google Scholar]
  5. Proc. Am. Soc. Clin. Oncol., 1989, 8 [Google Scholar]
  6. “Carboplatin Workshop Abstracts”, Bristol-Myers, 1989 [Google Scholar]
  7. Tarr I. “Cancer Chemotherapy Report”, PJB Publications, Richmond, England, 1989 [Google Scholar]

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error